Herbert W. Boyer

from Wikipedia, the free encyclopedia
Herbert Boyer

Herbert Wayne Boyer (born July 10, 1936 in Pittsburgh , Pennsylvania , United States ) is an American biochemist and one of the founders of the first biotechnology company Genentech .

In 1963 Boyer graduated from the University of Pittsburgh with degrees in biology and chemistry . He then worked for three years at Yale University on proteins and enzymes . In 1966 he went to the University of California, San Francisco as an assistant professor , where he researched Escherichia coli . Together with Stanley N. Cohen from Stanford University , he developed the technique of incorporating foreign DNA ( recombinant DNA ) into bacterial cells and stimulating them to express . In 1978, researchers from the City of Hope National Medical Center made the first synthetic insulin .

In 1976 Boyer founded Genentech together with financial investor Robert A. Swanson in order to profitably use his work. In 1985 they were the first biotechnology company to bring their own drug (genetically engineered somatotropin ) onto the market. In 2001 he retired.

Awards

In 1979 he was admitted to the American Academy of Arts and Sciences , and in 1985 to the National Academy of Sciences . In 1988 he became a Fellow of the American Association for the Advancement of Science . In 1980 Boyer received the Albert Lasker Award for Basic Medical Research and in 2000 the Biotechnology Heritage Award . In 2004 he was awarded the Shaw Prize and the Albany Medical Center Prize . In 2007 he received the Perkin Medal .

Individual evidence

  1. The Pioneers of Molecular Biology: Herb Boyer , Time Magazine, March 9, 1981 cover of TIME. February 9, 2002. Retrieved May 4, 2010.